John Jesitus is a medical writer based in Westminster, CO.
Much promise, challenge remains with current and future vaccines
August 1st 2012In the quest for new vaccines, developers must balance clinical promise with practical concerns, said Kenneth Tomecki, M.D., at the 70th annual meeting of the American Academy of Dermatology. "The future for vaccines is very encouraging," says Dr. Tomecki, vice chairman, department of dermatology, Cleveland Clinic.
Photodynamic therapy serves many medical, aesthetic purposes
August 1st 2012The safety and versatility of photodynamic therapy (PDT) make it a worthwhile addition for dermatologists not yet providing this treatment, according to Amy Forman Taub, M.D., who spoke at the 2011 annual meeting of the American Society of Cosmetic Dermatology and Aesthetic Surgery.
IOM recommendations for vitamin D intake play it safe, physician says
August 1st 2012Aside from hypercalcemia, risks of acute or chronic vitamin D doses above the level deemed safe by the Institute of Medicine are perhaps real, but they’re difficult to measure at present, says Christopher Burnett, M.D.
MRSA fight rages on with new drugs, time-tested protection
July 1st 2012Newer drugs are available to combat potentially serious infections including methicillin-resistant Staphylococcus aureus (MRSA), says Kenneth J. Tomecki, M.D., vice-chairman, department of dermatology, Cleveland Clinic. Colonization, mainly of the anterior nares, remains a major risk factor for MRSA.
New microwave-based device zaps hyperhidrosis
June 1st 2012"A new microwave-based device is achieving long-lasting results in treating hyperhidrosis, said Suzanne L. Kilmer, M.D., at this year's MauiDerm: Advances in Cosmetic and Medical Dermatology. Approved for primary axillary hyperhidrosis in January 2011, the miraDry System (Miramar Labs) essentially kills targeted sweat glands with microwave energy."
Sentinel lymph node biopsy appropriate for certain thin melanomas
June 1st 2012Sentinel lymph node (SLN) status represents the most important prognostic factor for disease-specific survival in primary cutaneous melanomas, said Christopher K. Bichakjian, M.D., at the 70th annual meeting of the American Academy of Dermatology. However, he says, its impact on overall survival remains unclear.
For certain congenital melanocytic nevi, surgery not the answer
April 1st 2010Since there is insufficient evidence to recommend for or against prophylatic surgery for patients with congenital melanocytic nevi, physicians need to tailor management based on factors such as the size, thickness and locations of lesions for each patient, an expert says.
CertifyingEHR: AAD takes lead on dermatology-specific criteria
November 1st 2009Because commercially available EHR systems have largely ignored the needs of dermatology practices, the American Academy of Dermatology (AAD) has taken a lead role in the creation of dermatology-specific EHR certification criteria, sources say.
Embracing diversity: New skin type system addresses procedures for treating skin of color
November 1st 2009As the presence and diversity of ethnic skin of color (SOC) continue to grow worldwide, an expert says a more comprehensive skin-type classification system will help dermatologists predict these patients' response to dermatologic procedures.
Evaluating EHRs: Cost, frustration temper advantages of electronic health record systems
November 1st 2009With the Obama administration's 2014 goal for national electronic medical record (EMR) adoption looming, dermatologists who have taken the plunge say the systems carry hefty costs and require steep learning curves.
Going too far? Derms question pediatric warning for TN
October 1st 2009Although hardly unexpected, the Food and Drug Administration's decision to add a warning about a possible link between tumor necrosis factor (TNF) antagonists and cancer in children goes too far, say most dermatologists contacted by Dermatology Times.